Tablet capping observed during compression – FDA inspection observation risk
Identifying symptoms of tablet capping is paramount for initiating a timely investigation. Key signals may include:Click to read the full article.
Tablet Manufacturing Defects
Tablet capping observed during stability pull – root cause analysis breakdown
Recognizing the symptoms of tablet capping early allows for timely intervention. Some common signals include:Click to read the full article.
Friability failure after scale-up – process vs formulation assessment
In the context of tablet production, friability primarily refers to the tendency of tablets to crumble or break apart during handling and storage. Symptoms suggesting a friability failure typically include:Click…
Tablet capping observed after tooling change – FDA inspection observation risk
Identifying symptoms of tablet capping shortly after a tooling change is crucial for early intervention. Common signals that may indicate a capping issue include:Click to read the full article.
Hardness drift during campaign changeover – root cause analysis breakdown
The first indicator of hardness drift during a campaign changeover is typically observed during routine quality control checks. Symptoms may include:Click to read the full article.
Tablet lamination defect during stability pull – process vs formulation assessment
Identifying symptoms of tablet lamination defects is the first step in the investigation process. Symptoms include visible separation of layers in the tablet, uneven surfaces, or compromised structural integrity during…
Hardness drift after tooling change – process vs formulation assessment
Identifying the symptoms of hardness drift is crucial in initiating a timely investigation. Symptoms may manifest as deviations in the expected tablet hardness values, which can be observed through:Click to…
Black specks detected during campaign changeover – FDA inspection observation risk
The detection of black specks can manifest in various ways during the manufacturing process, primarily during tablet production. Staff may report the presence of black particles during visual inspections, either…
Friability failure during stability pull – process vs formulation assessment
Identifying signals of potential friability failures during stability pulls is crucial. Symptoms may include:Click to read the full article.
Content uniformity OOS during campaign changeover – FDA inspection observation risk
Content uniformity is a critical quality attribute that ensures that each dosage unit contains the appropriate amount of active pharmaceutical ingredient (API). Symptoms indicating a problem may include:Click to read…
Disintegration time failure during campaign changeover – FDA inspection observation risk
Disintegration time failures can manifest in various ways during the manufacturing process. It is crucial to monitor critical indicators systematically as these signals can herald potential deviations or complaints. Symptoms…
Friability failure after scale-up – CAPA failure identified
Friability, or the tendency of a tablet to crumble under conditions of handling and storage, often signals underlying issues in manufacturing. Observations on the production floor or in quality control…